Is COVID-19 masking the ongoing youth vaping crisis?
Open Access
- 26 May 2021
- journal article
- editorial
- Published by Taylor & Francis in Expert Review of Respiratory Medicine
- Vol. 15 (9) , 1089-1091
Abstract
E-cigarette, or vaping, product use-associated lung injury (EVALI) is a life-threatening, acute respiratory illness that came to international prominence in 2019 [1,2]. Starting that spring, public...Keywords
This publication has 36 references indexed in Scilit:
- Pulmonary Illness Related to E-Cigarette Use in Illinois and Wisconsin — Final ReportNew England Journal of Medicine, 2020
- e-Cigarette Use Among Youth in the United States, 2019JAMA, 2019
- Clinical presentation, treatment, and short-term outcomes of lung injury associated with e-cigarettes or vaping: a prospective observational cohort studyThe Lancet, 2019
- E-cigarette, or vaping, product use associated lung injury (EVALI): case series and diagnostic approachThe Lancet Respiratory Medicine, 2019
- Life-threatening bronchiolitis related to electronic cigarette use in a Canadian youthCanadian Medical Association Journal, 2019
- Evaluation of Bronchoalveolar Lavage Fluid from Patients in an Outbreak of E-cigarette, or Vaping, Product Use–Associated Lung Injury — 10 States, August–October 2019MMWR. Morbidity and Mortality Weekly Report, 2019
- Fourth generation e-cigarette vaping induces transient lung inflammation and gas exchange disturbances: results from two randomized clinical trialsAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2019
- A Randomized Trial of E-Cigarettes versus Nicotine-Replacement TherapyNew England Journal of Medicine, 2019
- Electronic cigarettes for smoking cessation: a randomised controlled trialThe Lancet, 2013
- TOBACCO SMOKING AS A POSSIBLE ETIOLOGIC FACTOR IN BRONCHIOGENIC CARCINOMAJAMA, 1950